We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (292)
- COVID-19 (164)
- Safety monitoring and information (120)
- Compliance and enforcement (93)
- Legislation (78)
- Manufacturing (60)
- Vaping hub (57)
- Labelling and packaging (43)
- Import and export (38)
- Medicinal cannabis hub (28)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1294 result(s) found, displaying 1101 to 1125
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
News articlesCommonly asked questions about stem cells and regulation
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Regulatory decision noticesNew requirements for caffeine and caffeine-containing ingredients within listed medicines
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
BlogWhen a company makes a medicine, quality is planned for with Good Manufacturing Practice.
-
Safety updatesMedicines Safety Update article
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
News articlesRecommended paracetamol doses and labelling requirements.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
Safety updatesSafety information: regulators review balloon and stent devices used to unblock blood vessels in the legs
-
News articlesThe TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
Media releasesInformation on how supplements are regulated in Australia
-
News articlesInformation for consumers on the use of performance and image enhancing drugs
-
News articlesChanges will be made to the regulation of nappy rash products on 1 January 2020
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
BlogIf you have any unwanted medicines, you can safely dispose of them at your local pharmacy.
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia